Steffen JA - Search Results

1

Technological evolution of diagnostic testing in oncology.

Steffen JA, Lenz C. Steffen JA, et al. Per Med. 2013 May;10(3):275-283. doi: 10.2217/pme.13.19. Per Med. 2013. PMID: 29768743 Free article.

2

Driving forces behind the past and future emergence of personalized medicine.

Steffen JA, Steffen JS. Steffen JA, et al. J Pers Med. 2013 Jan 17;3(1):14-22. doi: 10.3390/jpm3010014. J Pers Med. 2013. PMID: 25562408 Free PMC article.

3

Diffusion of molecular diagnostic lung cancer tests: a survey of german oncologists.

Steffen JA. Steffen JA. J Pers Med. 2014 Mar 21;4(1):102-14. doi: 10.3390/jpm4010102. J Pers Med. 2014. PMID: 25562146 Free PMC article.

4

Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast Group.

Barinoff J, Traut A, Bauerschlag D, Bischoff J, Herr D, Lübbe K, Lück HJ, Maass N, Mundhenke C, Schmidt M, Schwedler K, Thill M, Steffen J, Loibl S, von Minckwitz G. Barinoff J, et al. Geburtshilfe Frauenheilkd. 2013 May;73(5):433-439. doi: 10.1055/s-0032-1328612. Geburtshilfe Frauenheilkd. 2013. PMID: 24771923 Free PMC article.

5

Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765).

Noske A, Loibl S, Darb-Esfahani S, Roller M, Kronenwett R, Müller BM, Steffen J, von Toerne C, Wirtz R, Baumann I, Hoffmann G, Heinrich G, Grasshoff ST, Ulmer HU, Denkert C, von Minckwitz G. Noske A, et al. Breast Cancer Res Treat. 2011 Feb;126(1):109-17. doi: 10.1007/s10549-010-1316-y. Epub 2010 Dec 29. Breast Cancer Res Treat. 2011. PMID: 21190079 Clinical Trial.

6

Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer.

Kobold S, Steffen J, Chaloupka M, Grassmann S, Henkel J, Castoldi R, Zeng Y, Chmielewski M, Schmollinger JC, Schnurr M, Rothenfußer S, Schendel DJ, Abken H, Sustmann C, Niederfellner G, Klein C, Bourquin C, Endres S. Kobold S, et al. J Natl Cancer Inst. 2014 Nov 24;107(1):364. doi: 10.1093/jnci/dju364. Print 2015 Jan. J Natl Cancer Inst. 2014. PMID: 25424197

7

The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.

Trad KS, Barnes WE, Prevou ER, Simoni G, Steffen JA, Shughoury AB, Raza M, Heise JA, Fox MA, Mavrelis PG. Trad KS, et al. Among authors: steffen ja. Surg Innov. 2018 Apr;25(2):149-157. doi: 10.1177/1553350618755214. Epub 2018 Feb 6. Surg Innov. 2018. PMID: 29405886 Free PMC article. Clinical Trial.

8

The Prevalence of Congenital Hand and Upper Extremity Anomalies Based Upon the New York Congenital Malformations Registry.

Goldfarb CA, Shaw N, Steffen JA, Wall LB. Goldfarb CA, et al. Among authors: steffen ja. J Pediatr Orthop. 2017 Mar;37(2):144-148. doi: 10.1097/BPO.0000000000000748. J Pediatr Orthop. 2017. PMID: 27078227 Free PMC article.

9

The effect of soft tissue distraction on deformity recurrence after centralization for radial longitudinal deficiency.

Manske MC, Wall LB, Steffen JA, Goldfarb CA. Manske MC, et al. Among authors: steffen ja. J Hand Surg Am. 2014 May;39(5):895-901. doi: 10.1016/j.jhsa.2014.01.015. Epub 2014 Mar 1. J Hand Surg Am. 2014. PMID: 24594270

10

Intermediate-term to long-term outcome of surgically and nonsurgically treated congenital, isolated radial head dislocation.

Bengard MJ, Calfee RP, Steffen JA, Goldfarb CA. Bengard MJ, et al. Among authors: steffen ja. J Hand Surg Am. 2012 Dec;37(12):2495-501. doi: 10.1016/j.jhsa.2012.08.032. Epub 2012 Nov 1. J Hand Surg Am. 2012. PMID: 23123151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page